Lumavita emerges from Shogoo and raises CHF18 million
This article was originally published in Scrip
Executive Summary
A new biopharmaceutical company Lumavita has been formed in Basle, Switzerland, out of Shogoo Pharmaceuticals to focus on anti-infectives in women's health. Shogoo KK, a Japanese biopharmaceutical company, is currently in the process of winding down its operations, but its Swiss pharmaceutical subsidiary has been reformed into Lumavita, which is set to continue the operations of the now defunct Shogoo.